SANOFI
SAN.PA
€ 86,89
1,95%
Marketcap
108,46B
Volume
€ 1.871.390,00
Shares
1.248.230.016
Range
€ 85,07 – € 86,98
52 Week Range
€ 80,60 – € 105,18

More Info for SANOFI (SAN.PA)

  • Charts
  • Brokers

  • Description

  • News

  • Comments

Stocks Brokers
Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.
SANOFI
Symbol: SAN.PA
Employees: 91573
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson’s disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
PAR
Healthcare
Drug Manufacturers – General
46, avenue de la Grande Arm e, Paris, France
France

How to invest on SANOFI?

To invest or trade stocks SANOFI you need a broker to execute your positions.
But before directing you to a broker compatible with your needs, I would like to give you a Stock Summary on SANOFI.

SANOFI(SAN.PA) stock market review

The company SANOFI based in France, is specialized in the Drug Manufacturers – General industry, the Healthcare sector and employs more than 91.573 employees.

The SANOFI (SAN.PA) share price is currently € 86,89 with 1.248.230.016 shares outstanding, representing a market cap of € 108.458.704.896,00. The daily volume is 1.871.390 and the previous close of the share value was € 85,23.
Over the past 52 weeks, the stock has traded low at € 80,60 and high at € 105,18.
SANOFI offers earnings per share of 4.3.
Regarding dividends, the dividend yield for SANOFI is 4.41 and the dividend rate is 3.76.

Choose a Broker to trade on SANOFI

There are several things to check before taking your first steps with your new broker. This is the reason why at AdonFinance we find the broker that suits you. To view the article on how to choose a broker, go to the site menu, and click on Brokers.

To choose a broker who offers the possibility of trading on the SANOFI (SAN.PA ) share, click on the button below:

Find Brokers for SANOFI (SAN.PA)

Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.

Leave a Reply

Your email address will not be published. Required fields are marked *

AdonFinance
Risk Warning: The material on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory or other services by AdonFinance. In addition, the content of the website offers no opinion with respect to the suitability of any security or any specific investment. Trading foreign exchange, stocks, cryptocurrencies and commodities is potentially high risk and may not be suitable for all investors. The high level of leverage can work both for and against traders. Before any investment with any broker you need to carefully consider your targets, previous experience, and risk level. Forex trading can result in the loss of your money, as a result, you are expressly cautioned that you should never invest or trade with money that you cannot afford to lose. For the avoidance of doubt, AdonFinance's service provides Brokers reviews in the Financial market. AdonFinance, its subsidiaries, agents or affiliates will assume no responsibility whatsoever for your trading activity. © Copyright 2021 AdonFinance